Antimelanogenic activity of a novel adamantyl benzylbenzamide derivative, AP736: a randomized, double-blind, vehicle-controlled comparative clinical trial performed in patients with hyperpigmentation during the summer
2015 ◽
Vol 55
(6)
◽
pp. e321-e326
◽
1976 ◽
Vol 4
(3)
◽
pp. 179-182
◽
Keyword(s):
1975 ◽
Vol 3
(4)
◽
pp. 251-260
◽
2009 ◽
Vol 31
(12)
◽
pp. 2860-2872
◽
Keyword(s):
2010 ◽
Vol 21
(5)
◽
pp. 286-293
◽
1979 ◽
Vol 7
(4)
◽
pp. 272-276
◽
1974 ◽
Vol 2
(1)
◽
pp. 66-70
◽
2013 ◽
Vol 03
(04)
◽
pp. 250-255
2010 ◽
Vol 10
(1)
◽
pp. 1
◽
2004 ◽
Vol 12
(1)
◽
pp. 57
Keyword(s):